No Data
No Data
2024 INTERIM REPORT
Brokers Suggest Investing in JD.com (JD): Read This Before Placing a Bet
Walmart Sells Stake in JD.com; JD.com Shares Plunge 6%
JD Health (06618): According to the first public offering, 1 million new shares will be issued under the stock incentive plan after the initial public offering.
JD Health (06618) announced that according to the first public offering after the stock...
Brokerage Focus: Tianfeng Securities maintains a "buy" rating on JD Health (06618), pointing out that the gradual opening of online medical insurance drug purchases is expected to open up medium- to long-term growth space.
According to Tianfeng's research report, jd health (06618) achieved revenue of 28.344 billion yuan in the first half of 2024, a year-on-year increase of 4.6% from 27.1 billion yuan in the same period last year. In terms of business, the company's self-operated commodity revenue in the first half of 2024 was 23.91 billion yuan, a year-on-year increase of 3.2%; service revenue was 4.43 billion yuan, a year-on-year increase of 12.5%.
Intelligent Communications Hong Kong Stocks Short Selling Statistics | August 21
Short selling statistics of Hong Kong stocks | August 21st
No Data
No Data